Published: Guidance, quality standards and advice
Showing 11 to 16 of 16
Title | Reference number | Published | Last updated |
---|---|---|---|
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal) | TA351 | ||
Hypersexuality: fluoxetine | ESUOM46 | ||
Spiral Flow peripheral vascular graft for treating peripheral arterial disease | MIB34 | ||
BD MAX Enteric Bacterial Panel for identifying pathogens in contagious gastroenteritis | MIB32 | ||
Type 2 diabetes: insulin degludec/liraglutide (Xultophy) | ESNM60 | ||
Nutrition: improving maternal and child nutrition | QS98 |